NECLIFE

HealthcareDrug Manufacturers - Specialty & GenericMicro Cap
Nectar Lifesciences Limited

Nectar Lifesciences Limited (NECLIFE) operates in the Healthcare sector as a Drug Manufacturer - Specialty & Generic. The company manufactures, distributes, markets, and sells phar...

हिन्दी में

Nectar Lifesciences Limited (NECLIFE) स्वास्थ्य सेवा क्षेत्र में एक विशेष एवं जेनेरिक दवा निर्माता के रूप में कार्यरत है। यह कंपनी भारत और अंतरराष्ट्रीय स्तर पर फार्मास्युटिकल उत्प...

₹10.13-3.98%1D
Previous trading day close · Data updates after market close
1W: -3.3%
1M: -15.4%
6M: -14.9%
1Y: -30.6%
46/100
Below AvgResearch Score
Market Cap
₹223 Cr
Micro Cap
P/E Ratio
-0.78
Negative earnings
P/B Ratio
0.24
Reasonable
ROE
-11.2%
Weak
ROCE
-28.0%
Average
Debt / Equity
0.61
Moderate
Div. Yield
N/A
EV/EBITDA
N/A
52W Low: ₹9.3Current: ₹10.1352W High: ₹22.4
At 6% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
39/100
Growth
Revenue, EPS, profit growth
34/100
Valuation
PE, PB, EV/EBITDA vs sector
57/100
Risk
Debt levels, volatility, coverage
62/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
-0.78(Negative earnings)
Forward P/E
N/A
P/B Ratio
0.24(Reasonable)
P/S Ratio
24.57(Expensive)
EV/EBITDA
N/A
Dividend Yield
N/A
5Y CAGR
-21.9%(Moderate)
Revenue Growth
-99.4%(Moderate)
Profitability
ROE
-11.2%(Average)
ROCE
-28.0%(Average)
ROA
-5.4%(Average)
Net Margin
-3152.9%(Low)
EBITDA Margin
-3088.9%
Financial Health
Debt to Equity
0.61(Moderate)
Current Ratio
1.21(Tight)
Quick Ratio
0.54(Tight)
Interest Coverage
-7.95x(Low)
Technical Indicators
Based on previous trading day close
RSI (14)
35(Neutral)
RSI Exp (14)
33(Neutral)
MACD
-0.267(Bearish)
MACD Signal
-0.212
BB Position
7%(Lower band)
BB Width
15.49%(Normal)
ADX (14)
55.5(Very Strong)
Williams %R
-91.5(Oversold)
MFI (14)
25(Neutral)
CCI (20)
-140(Oversold)
Stoch %K
9(Oversold)
ATR (14)
0.49(Avg True Range)
OBV (M)
108.3(Positive)
1W OBV Chg
0.2%(Increasing)
Rel Volume
1.04x(Normal)
Volatility
56.3%(High)
Max DD 1Y
-78.8%(High loss)
EMA 200
12.9
EMA 50
11.1
SMA 200
12.4
vs SMA 50
-8.9%(Below SMA50)
vs SMA 200
-18.5%(Below SMA200)
Volume
2.05L
Avg Vol 3M
2.0L
Shareholding Pattern
Promoter
51.8%
High confidence
FII
0.6%
DII / MF
4.0%
Share NECLIFE
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.